Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.

Rowland KJ, Trivedi S, Lee D, Wan K, Kulkarni RN, Holzenberger M, Brubaker PL.

Gastroenterology. 2011 Dec;141(6):2166-2175.e7. doi: 10.1053/j.gastro.2011.09.014. Epub 2011 Sep 16.

PMID:
21925122
2.

The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.

Dubé PE, Forse CL, Bahrami J, Brubaker PL.

Gastroenterology. 2006 Aug;131(2):589-605. Erratum in: Gastroenterology. 2007 Mar;132(3):1208.

PMID:
16890611
3.

Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.

Dubé PE, Rowland KJ, Brubaker PL.

Endocrinology. 2008 Jan;149(1):291-301. Epub 2007 Sep 20.

PMID:
17884945
4.

Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.

Shin ED, Estall JL, Izzo A, Drucker DJ, Brubaker PL.

Gastroenterology. 2005 May;128(5):1340-53. Erratum in: Gastroenterology. 2007 Mar;132(3):1208.

PMID:
15887116
5.

ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.

Bahrami J, Yusta B, Drucker DJ.

Gastroenterology. 2010 Jun;138(7):2447-56. doi: 10.1053/j.gastro.2010.03.006. Epub 2010 Mar 10.

PMID:
20226187
6.

The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model.

Taqi E, Wallace LE, de Heuvel E, Chelikani PK, Zheng H, Berthoud HR, Holst JJ, Sigalet DL.

J Pediatr Surg. 2010 May;45(5):987-95. doi: 10.1016/j.jpedsurg.2010.02.036.

PMID:
20438940
7.

The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.

Dong CX, Zhao W, Solomon C, Rowland KJ, Ackerley C, Robine S, Holzenberger M, Gonska T, Brubaker PL.

Endocrinology. 2014 Feb;155(2):370-9. doi: 10.1210/en.2013-1871. Epub 2013 Nov 21.

PMID:
24265452
8.

Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.

McDonagh SC, Lee J, Izzo A, Brubaker PL.

Am J Physiol Gastrointest Liver Physiol. 2007 Aug;293(2):G461-8. Epub 2007 Jun 21.

9.

IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestine.

Austin K, Imam NA, Pintar JE, Brubaker PL.

Endocrinology. 2015 Feb;156(2):429-36. doi: 10.1210/en.2014-1829. Epub 2014 Dec 16.

10.

Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.

Anini Y, Izzo A, Oudit GY, Backx PH, Brubaker PL.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1599-606. Epub 2007 Feb 6.

11.

Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I.

Ohneda K, Ulshen MH, Fuller CR, D'Ercole AJ, Lund PK.

Gastroenterology. 1997 Feb;112(2):444-54.

PMID:
9024298
12.

Intestinal growth-promoting properties of glucagon-like peptide-2 in mice.

Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ.

Am J Physiol. 1997 Jul;273(1 Pt 1):E77-84.

PMID:
9252482
13.

ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.

Yusta B, Holland D, Koehler JA, Maziarz M, Estall JL, Higgins R, Drucker DJ.

Gastroenterology. 2009 Sep;137(3):986-96. doi: 10.1053/j.gastro.2009.05.057. Epub 2009 Jun 9.

PMID:
19523469
14.

Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.

Bahrami J, Longuet C, Baggio LL, Li K, Drucker DJ.

Gastroenterology. 2010 Sep;139(3):857-68. doi: 10.1053/j.gastro.2010.05.006. Epub 2010 Jun 11.

PMID:
20546737
15.

The "cryptic" mechanism of action of glucagon-like peptide-2.

Rowland KJ, Brubaker PL.

Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G1-8. doi: 10.1152/ajpgi.00039.2011. Epub 2011 Apr 28. Review.

16.

Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2.

Ivory CP, Wallace LE, McCafferty DM, Sigalet DL.

Am J Physiol Gastrointest Liver Physiol. 2008 Dec;295(6):G1202-10. doi: 10.1152/ajpgi.90494.2008. Epub 2008 Oct 9.

17.

Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet.

Baldassano S, Amato A, Cappello F, Rappa F, Mulè F.

J Endocrinol. 2013 Mar 15;217(1):11-20. doi: 10.1530/JOE-12-0500. Print 2013 Apr.

18.

Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.

Murali SG, Brinkman AS, Solverson P, Pun W, Pintar JE, Ney DM.

Am J Physiol Gastrointest Liver Physiol. 2012 Apr 15;302(8):G794-804. doi: 10.1152/ajpgi.00372.2011. Epub 2012 Jan 26.

19.

Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators.

Dubé PE, Brubaker PL.

Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E460-5. Epub 2007 Jul 24. Review.

20.

Supplemental Content

Support Center